Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy.
about
Progression of temporal processing deficits in the HIV-1 transgenic ratGetting to 90-90-90 in paediatric HIV: What is needed?Host genetic factors predisposing to HIV-associated neurocognitive disorder.Early viral suppression improves neurocognitive outcomes in HIV-infected children.Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection?Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders.Comparison of developmental milestone attainment in early treated HIV-infected infants versus HIV-unexposed infants: a prospective cohort study.Default Mode Connectivity in Youth With Perinatally Acquired HIV.The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected childrenLearning and Memory in Children and Adolescents With Perinatal HIV Infection and Perinatal HIV ExposureNeurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.Lower total and regional grey matter brain volumes in youth with perinatally-acquired HIV infection: Associations with HIV disease severity, substance use, and cognition.The role of neuropsychology in UK pediatric HIV care: Relevance to clinical practice and research.Treatment of perinatal viral infections to improve neurologic outcomes.Mental health challenges among adolescents living with HIVCross-cultural assessment of HIV-associated cognitive impairment using the Kaufman assessment battery for children: a systematic review.Executive Functioning in Children and Adolescents With Perinatal HIV Infection and Perinatal HIV Exposure.Deformed Subcortical Structures Are Related to Past HIV Disease Severity in Youth With Perinatally Acquired HIV Infection.Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1.Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters.Sex Matters: Robust Sex Differences in Signal Detection in the HIV-1 Transgenic Rat.Implications of Combined Exposure to Household Air Pollution and HIV on Neurocognition in Children.Opiate Drugs with Abuse Liability Hijack the Endogenous Opioid System to Disrupt Neuronal and Glial Maturation in the Central Nervous System.Improved Neurodevelopment Following Antiretroviral Therapy in HIV-Infected Children.
P2860
Q30374656-4292DCC0-5373-4669-BBCB-955281C38F1AQ30385352-986C80D4-3DF4-4168-B1A7-8E99DAAC33EEQ34001122-89FC35DC-AC24-4EFF-B6E2-56F6D10B6B55Q35095168-E4D960D0-9C17-42EA-9A68-939218F50D5EQ35984276-18672045-34A8-4252-A8BF-62BB7E0EBAE4Q36169735-62250047-7144-4EE9-AB14-5E5BFAA99AE1Q36251762-D94E065D-450A-4A9A-9F9A-F244D551CD70Q36256071-42A09DE2-F9D7-42CC-A572-BFD62EBFB235Q36349683-6E28A81E-FAAA-4E3F-842C-155F3AFFAB14Q36896578-DBD9F029-1361-4955-88CB-5A2847DDE0A4Q37205326-7CAACB20-2A11-4BE1-A80D-AB0DFE33E789Q38770217-147D2D97-219D-4C97-BCAB-87E1C94866B1Q38841035-516E3B8A-795F-4557-B1FD-161CEDCACD40Q38965659-8478D89E-E2D9-4F0B-B9EA-2787082EC759Q39321831-C8F08D7D-76AD-4B80-87F1-C059EAC74CC6Q39406562-E6C519E5-01CB-4659-B5BF-5BD2C3EEB17CQ40447351-69EE4850-828B-4088-A8F3-493028F21461Q40447357-0AA51310-36BA-4E51-960D-A88AAEE2C4ECQ40570704-0B4A91BB-A702-46E4-95DF-861229C24401Q47432196-1BC8F504-2F60-4E4D-9DCE-35DBA91773EFQ47574273-34766624-D3FA-4750-BD6F-168EDF3144AEQ48182789-ADEA2EEC-C357-4517-BC5C-A7B2358703E4Q49270407-FE0F6F37-ED32-4BC3-A046-25AD4D4BB39DQ50042626-B998CEDA-6635-44F8-AC9B-915491A3AAEC
P2860
Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Neurologic disease in HIV-infe ...... nation antiretroviral therapy.
@en
type
label
Neurologic disease in HIV-infe ...... nation antiretroviral therapy.
@en
prefLabel
Neurologic disease in HIV-infe ...... nation antiretroviral therapy.
@en
P2093
P2860
P356
P1476
Neurologic disease in HIV-infe ...... nation antiretroviral therapy.
@en
P2093
Claudia S Crowell
Kathleen M Malee
P2860
P304
P356
10.1002/RMV.1793
P50
P577
2014-05-08T00:00:00Z